Selling The Skinny
With the threats from compounders and generics mostly contained, we can take a look at the latest piece of GLP-1 news.
With the threats from compounders and generics mostly contained, we can take a look at the latest piece of GLP-1 news.
Much like America's waistline, a dispute between Eli Lilly and a large compounder called Empower Pharmacy is expanding.
Explore the mindset, cultural shifts, and training strategies that define the AI‑savvy lawyer, revealing why human judgment, standardized competence, and integrated learning—not technology alone—will shape the future of the profession.
Considering how these drug giants are patenting privation gives an interesting look at where Mounjaro and Wegovy may be headed, as well as what IP strategies they are following to keep their profits as fat as possible for as long as possible.